Slika na naslovnici

Low Pre-ChemoradiotherapyPan-Immune-Inflammation Value (PIV) Measures Predict Better Survival Outcomes in Locally Advanced Pancreatic Adenocarcinomas

Erkan Topkan,1 Ugur Selek,2,3 Ahmet Kucuk,4 Berrin Pehlivan5 1Department of Radiation Oncology, Baskent University Medical Faculty, Adana, Turkey; 2Department of Radiation Oncology, Koc University School of Medicine, Istanbul, Turkey; 3Division of Radiation Oncology, The University of Texas MD Ander...

Shranjeno v:

Bibliografske podrobnosti
Main Authors:	Topkan E (Author), Selek U (Author), Kucuk A (Author), Pehlivan B (Author)
Format:	Knjiga
Izdano:	Dove Medical Press, 2022-09-01T00:00:00Z.
Teme:	article
Online dostop:	Connect to this object online.
Oznake:	Označite Brez oznak, prvi označite!

Podobne knjige/članki

High Measures of Pre-Chemoradiotherapy Platelet-to-Albumin Ratio Indicates Poor Prognosis in Locally Advanced Pancreatic Cancer Patients
od: Kucuk A, et al.
Izdano: (2022)

The predictive value of pretreatment hemoglobin-to-platelet ratio on osteoradionecrosis incidence rates of locally advanced nasopharyngeal cancer patients managed with concurrent chemoradiotherapy
od: Busra Yilmaz, et al.
Izdano: (2023)

The Prognostic Significance of Novel Pancreas Cancer Prognostic Index in Unresectable Locally Advanced Pancreas Cancers Treated with Definitive Concurrent Chemoradiotherapy
od: Topkan E, et al.
Izdano: (2021)

Pretreatment Systemic Immune-Inflammation Index Predict Needs for Teeth Extractions for Locally Advanced Head and Neck Cancer Patients Undergoing Concurrent Chemoradiotherapy
od: Yilmaz B, et al.
Izdano: (2021)

High Pretreatment Platelet-to-Albumin Ratio Predicts Poor Survival Results in Locally Advanced Nasopharyngeal Cancers Treated with Chemoradiotherapy
od: Haksoyler V, et al.
Izdano: (2021)

Disparities in Survival Outcomes Between Locally Advanced Cervical Squamous Cell Carcinoma and Adenocarcinoma Treated with Chemoradiotherapy
od: Hong SS, et al.
Izdano: (2024)

The Baseline Pan-Immune‑Inflammation Value (PIV) and PILE in Predicting Clinical Outcomes and Therapeutic Response for Primary Central Nervous System Lymphoma
od: Duan L, et al.
Izdano: (2024)

Prognostic Value of Pretreatment Systemic Immune-Inflammation Index in Glioblastoma Multiforme Patients Undergoing Postneurosurgical Radiotherapy Plus Concurrent and Adjuvant Temozolomide
od: Erkan Topkan, et al.
Izdano: (2020)

Prognostic Value of C-Reactive Protein to Albumin Ratio in Glioblastoma Multiforme Patients Treated with Concurrent Radiotherapy and Temozolomide
od: Erkan Topkan, et al.
Izdano: (2020)

Content Translation And Validation Of The Pediatric PIV Infiltration Scale Into Brazilian Portuguese
od: Elisa da Conceição Rodrigues, et al.

Post-neoadjuvant chemoradiotherapy tumor resectability following induction chemotherapy in locally advanced proximal gastric and adenocarcinoma of the esophagogastric junction: A clinical trial
od: Seyed Amir Aledavood, et al.
Izdano: (2021)

Do the Well Known Prognostic Parameters in Pancreatic Ductal Adenocarcinoma Really Reflect Survival?
od: Sonay KUŞ ÖZTÜRK, et al.
Izdano: (2018)

Evaluation of survival and recurrence patterns in esophageal cancer patients with pathological response to neoadjuvant chemoradiotherapy
od: Ali Kermani, et al.
Izdano: (2020)

LncRNAs Associated with Chemoradiotherapy Response and Prognosis in Locally Advanced Rectal Cancer
od: Zhang Y, et al.
Izdano: (2021)

Prospective trial to evaluate the prognostic value of different nutritional assessment scores for survival in pancreatic ductal adenocarcinoma (NURIMAS Pancreas SURVIVAL)
od: Max Heckler, et al.
Izdano: (2021)

The effectiveness of neoadjuvant chemoradiotherapy in oesophageal adenocarcinoma with presence of extracellular mucin, signet‐ring cells, and/or poorly cohesive cells
od: Maria J Valkema, et al.
Izdano: (2023)

Association of plasma levetiracetam concentration, MGMT methylation and sex with survival of chemoradiotherapy-treated glioblastoma patients
od: Federico Cucchiara, et al.
Izdano: (2022)

Pan-immune-inflammation value and body mass index to predict survival in diffuse large B-cell lymphoma
od: Mohamed Ahmed Abdel Hafez, et al.
Izdano: (2024)

Is it Possible to Successfully Treat Locally Advanced Colon Cancer Using Pre-Operative Chemoradiotherapy?
od: Ji Hun Choi, et al.
Izdano: (2019)

The Outcome of Induction Chemotherapy, Followed by Neoadjuvant Chemoradiotherapy and Surgery, in Locally Advanced Rectal Cancer
od: Ali Yaghobi Joybari, et al.
Izdano: (2021)

Comment on: The relevance of dental management prior to radiation therapy with severe oral mucositis in head and neck cancer patients
od: Erkan Topkan, et al.
Izdano: (2024)

In regard to Castagnola et al. (doi: 10.1186/s12903-023-03050-7)
od: Efsun Somay, et al.
Izdano: (2024)

Experimental determination of the velocity distribution in USP Apparatus 1 (basket apparatus) using Particle Image Velocimetry (PIV)
od: Chadakarn Sirasitthichoke, et al.
Izdano: (2021)

An Inflammatory Response Related Gene Signature Associated with Survival Outcome and Gemcitabine Response in Patients with Pancreatic Ductal Adenocarcinoma
od: Zhijun Xiao, et al.
Izdano: (2021)

Tumble Motion Evolution for GDI Engine using Particle Image Velocimetry (PIV) / Mohammed EL-Adawy ... [et al.]
od: EL-Adawy, Mohammed, et al.
Izdano: (2018)

Surgical Treatment of Pancreatic Ductal Adenocarcinoma
Izdano: (2021)

Comparisons of survivals and toxicities between young and elderly patients with cervical cancer treated with definitive radiotherapy or concurrent chemoradiotherapy
od: Weiping Wang, et al.
Izdano: (2019)

Model integrating CT-based radiomics and genomics for survival prediction in esophageal cancer patients receiving definitive chemoradiotherapy
od: Jinfeng Cui, et al.
Izdano: (2023)

Beta-blocker exposure and survival outcomes in patients with advanced pancreatic ductal adenocarcinoma: a retrospective cohort study (BETAPANC)
od: Antoine Le Bozec, et al.
Izdano: (2023)

Is Surgical Treatment an Option for Locally Advanced Cervical Cancer in the Presence of Central Residual Tumor after Chemoradiotherapy?
od: Samet Topuz, et al.
Izdano: (2020)

The clinical application of ctDNA to predict response to neoadjuvant chemoradiotherapy in patients with locally-advanced rectal cancer
od: Parmida Sadat Pezeshki, et al.
Izdano: (2023)

Predicting Neoadjuvant Chemoradiotherapy Response in Locally Advanced Rectal Cancer Using Tumor-Infiltrating Lymphocytes Density
od: Xu Y, et al.
Izdano: (2021)

Clinical Value of Systemic Immune Inflammation and Pan-Immune Inflammation in Adenoid Hypertrophy
od: Tuğba Yemiş, et al.
Izdano: (2024)

Targeting hyaluronan for the treatment of pancreatic ductal adenocarcinoma
od: Norihiro Sato, et al.
Izdano: (2016)

Therapeutic Targeting of Autophagy in Pancreatic Ductal Adenocarcinoma
od: Alexander G. Raufi, et al.
Izdano: (2021)

Drug Repurposing Opportunities in Pancreatic Ductal Adenocarcinoma
od: Rita Rebelo, et al.
Izdano: (2021)

A multidisciplinary approach is essential for differentiating autoimmune pancreatitis from pancreatic adenocarcinoma
od: Sung-Hoon Moon
Izdano: (2023)

CT and MRI Findings of Autoimmune Polymorph Bifocal Pancreatitis Mimicking Pancreatic Adenocarcinoma
od: Roman Rotzinger MD, et al.
Izdano: (2015)

Quantitative indexes of stromal markers expression in the pancreatic ductal adenocarcinoma and chronic pancreatitis
od: V. A. Tumanskiy, et al.
Izdano: (2015)

Pathomorphological description of proliferation and apoptosis processes in pancreatic intraepithelial neoplasia in the pancreatic ductal adenocarcinoma and chronic pancreatitis
od: V. A. Tumanskiy, et al.
Izdano: (2014)